Jones G, Ponsonby A L, Smith B J, Carmichael A
Menzies Centre for Population Health Research, University of Tasmania, Hobart, Australia.
J Asthma. 2000;37(7):603-11. doi: 10.3109/02770900009090816.
The aim of this cross-sectional study was to describe the role of asthma, asthma severity, and medication usage in bone mineralization of prepubertal children. Asthma severity, medication usage, and physical activity were assessed by questionnaire and objective measures in 330 children. Bone densitometry and body composition were measured by dual-energy x-ray absorptiometry. Asthma ever was reported by 110 subjects (33%). A diagnosis of asthma was not associated with any deficit in bone mass, whereas usage of inhaled corticosteroids (ICS) in the last year (but not past use) was associated with deficits in bone in the total body (only after adjustment for confounders), particularly for doses of > or =400 microg/day. These observations support current recommendations with regard to ICS usage in children, but require confirmation in longitudinal studies.
这项横断面研究的目的是描述哮喘、哮喘严重程度和药物使用在青春期前儿童骨矿化中的作用。通过问卷调查和客观测量方法对330名儿童的哮喘严重程度、药物使用情况和身体活动进行了评估。采用双能X线吸收法测量骨密度和身体成分。110名受试者(33%)报告曾患哮喘。哮喘诊断与骨量不足无关,而过去一年使用吸入性糖皮质激素(ICS)(而非既往使用情况)与全身骨量不足有关(仅在调整混杂因素后),尤其是剂量≥400微克/天的情况。这些观察结果支持目前关于儿童使用ICS的建议,但需要纵向研究加以证实。